Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Arthritis (1)
- Arthritis; Undifferentiated Connective Tissue Disease; Undifferentiated Systemic Rheumatic Disease; Inflammatory Joint Disease; Disease Modifying Anti-Rheumatic Drugs; hydroxychloroquine (1)
- Aspirin (1)
- DVT prophylaxis (1)
- Diagnosing DVT (1)
-
- Disease Modifying Anti-Rheumatic Drugs (1)
- Hydroxychloroquine (1)
- Inflammatory Joint Disease (1)
- LMWH (1)
- Pharmacology (1)
- TKA (1)
- TKA; DVT prophylaxis; pharmacology; aspirin; Xa inhibitors; LMWH; warfarin; VTE prophylaxis cost TKA; diagnosing DVT (1)
- Undifferentiated Connective Tissue Disease (1)
- Undifferentiated Systemic Rheumatic Disease (1)
- VTE prophylaxis cost TKA (1)
- Warfarin (1)
- Xa inhibitors (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Examination Of Venous Thromboembolism Prophylaxis In Patients Undergoing Total Knee Arthroplasty, William Kucera
Examination Of Venous Thromboembolism Prophylaxis In Patients Undergoing Total Knee Arthroplasty, William Kucera
Physician Assistant Scholarly Project Posters
Elective total knee arthroplasty (TKA) is the most frequently performed inpatient surgical procedure in the United States (Kurtz, Ong, Lau, Mowat, & Halpern 2007). Complications of this procedure include deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE). Various pharmacological agents exist for VTE prophylaxis. Warfarin and low-molecular-weight heparin (LMWH) were commonly used for VTE prophylaxis in the past, but with the emergence of novel anticoagulants including factor Xa inhibitors and direct thrombin inhibitors (DTIs), warfarin is used far less frequently. Aspirin is also approved for VTE prophylaxis. The purpose of this study was …
Treatment Of Undifferentiated Connective Tissue Disease With Csdmard’S Through Primary Care Providers In The Absence Of Intervention Via Rheumatology, Leslie Ann Anderson
Treatment Of Undifferentiated Connective Tissue Disease With Csdmard’S Through Primary Care Providers In The Absence Of Intervention Via Rheumatology, Leslie Ann Anderson
Physician Assistant Scholarly Project Papers
Undifferentiated connective tissue disease (UCTD) was first defined by Leroy over 30 years ago. UCTD is described as an autoimmune disease which presents similarly to other rheumatic diseases but fails to meet laboratory requirements which indicate a specific disease such as rheumatoid arthritis, systemic lupus erythematous, Sjogren's or scleroderma. Common signs and symptoms manifested by patients with UCTD include arthralgias, myalgias, fatigue, fever, Raynaud’s phenomenon and sicca like symptoms in addition to having a positive antinuclear antibody (ANA) test. Often patients with these symptoms are referred to rheumatology. Unfortunately, there is a shortage of rheumatology providers across the nation. Although …
Examination Of Venous Thromboembolism Prophylaxis In Patients Undergoing Total Knee Arthroplasty, William Kucera
Examination Of Venous Thromboembolism Prophylaxis In Patients Undergoing Total Knee Arthroplasty, William Kucera
Physician Assistant Scholarly Project Papers
Elective total knee arthroplasty (TKA) is the most frequently performed inpatient surgical procedure in the United States (Kurtz, Ong, Lau, Mowat, & Halpern 2007). Complications of this procedure include deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE). Various pharmacological agents exist for VTE prophylaxis. Warfarin and low-molecular-weight heparin (LMWH) were commonly used for VTE prophylaxis in the past, but with the emergence of novel anticoagulants including factor Xa inhibitors and direct thrombin inhibitors (DTIs), warfarin is used far less frequently. Aspirin is also approved for VTE prophylaxis. The purpose of this study was …
Treatment Of Undifferentiated Connective Tissue Disease By Primary Care Providers Using Csdmards, Leslie A. Anderson
Treatment Of Undifferentiated Connective Tissue Disease By Primary Care Providers Using Csdmards, Leslie A. Anderson
Physician Assistant Scholarly Project Posters
•Undifferentiated connective tissue disease (UCTD) is an autoimmune disease that presents similarly to other rheumatic conditions but fails to meet laboratory requirements which indicate a specific disease such as rheumatoid arthritis, systemic lupus erythematous, Sjogren's or scleroderma.
•UCTD presentation can include arthralgias, myalgias, fatigue, fever, Raynaud’s phenomenon and sicca like symptoms with a positive antinuclear antibody (ANA) test.
•Patients with UCTD symptoms are normally referred to rheumatology but a shortage exists leaving primary care providers to treat UCTD patients.
•Using disease modifying antirheumatic drugs (DMARDs) such as hydroxychloroquine is an option but it is not commonly prescribed by PCPs.
•The …